← TAKEDA PHARMACEUTICAL CO LTD

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Net Income — — — — — — $317.0b $144.1b $107.9b ($152.4b)
Net Income From Continuing Operations — — — — — — $317.0b $144.2b $108.1b ($152.1b)
Depreciation and amortization $171.4b $182.1b $272.4b $583.6b $559.7b $583.2b $664.4b $728.0b $761.4b $721.1b
Depreciation Amortization Depletion — — — — — — $664.4b $728.0b $761.4b $721.1b
Deferred Income Tax — — — — — — $58.1b ($91.4b) $66.9b $9.8b
Deferred Tax — — — — — — $58.1b ($91.4b) $66.9b $9.8b
Impairment losses $51.4b $13.5b $10.1b $101.9b $25.5b $54.5b $64.4b $150.0b $106.5b $145.7b
Equity-settled share-based compensation $15.4b $18.6b $20.1b $29.1b $37.7b $43.4b $60.7b $70.9b $72.9b $72.8b
Asset Impairment Charge — — — — — — $64.4b $150.0b $106.5b $145.7b
Adjustments For Income Tax Expense — — ($14.1b) ($105.0b) ($9.9b) $72.4b $58.1b ($91.4b) $66.9b —
Share of loss (profit) of investments accounted for using the equity method — — $43.6b $24.0b ($76.0m) $15.4b $8.6b ($6.5b) $4.0b $2.2b
Income tax expenses (benefit) $27.8b $30.5b ($14.1b) ($105.0b) ($9.9b) $72.4b $58.1b ($91.4b) $66.9b $9.8b
Earnings (Loss)es From Equity Investments — — — — — — $8.6b ($6.5b) $4.0b $2.2b
Additional Financial Items
Adjustments For Current Tax Of Prior Period — — ($10.9b) ($4.7b) ($12.2b) ($11.3b) ($17.5b) ($5.0b) ($4.7b) —
Adjustments For Finance Income — — ($66.4b) — — — — — — —
Adjustments For Unrealised Foreign Exchange Losses Gains — — ($2.7b) $399.0m $0 $0 — — — —
Goodwill — — $4.2t $4.0t $4.0t $4.4t $4.8t $5.4t $5.3t —
Payments Of Lease Liabilities Classified As Financing Activities — — — $30.0b $39.3b $39.7b $43.4b $54.6b $45.2b —
Payments To Acquire Or Redeem Entitys Shares — — $1.2b $3.7b $2.1b $77.5b $26.9b $2.3b $51.9b —
Proceeds From Borrowings Classified As Financing Activities — — $2.8t $496.2b $1.2t $249.3b $75.0b $100.0b $1.0t —
Purchase Of Intangible Assets Classified As Investing Activities — — $56.4b $90.6b $125.3b $62.8b $493.0b $305.3b $147.0b —
Purchase Of Interests In Associates — — — — — — — — $1.0b —
Repayments Of Borrowings Classified As Financing Activities — — $0 $701.1b $1.7t $810.1b $356.7b $320.9b $1.3t —
Net profit (loss) for the year $115.5b $186.7b $109.0b $44.3b $376.2b $230.2b $317.0b $144.2b $108.1b ($152.1b)
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements, net ($18.4b) $10.5b ($6.0b) ($18.4b) $59.3b ($11.2b) $4.0b $20.8b ($602.0m) $1.0b
Finance (income) and expenses, net — — $66.4b $137.2b $143.1b $142.9b $106.8b $167.8b $163.5b $146.4b
Decrease (increase) in trade and other receivables ($37.3b) ($647.0m) ($13.4b) ($34.8b) ($9.3b) $127.3b $75.1b $15.1b ($59.0b) ($70.2b)
Increase in inventories $3.9b $13.7b $58.7b $137.5b $26.0b ($46.1b) ($79.2b) ($115.7b) ($35.0b) ($61.3b)
Decrease in trade and other payables $42.6b $6.9b ($16.4b) ($29.9b) $36.6b $125.2b ($84.8b) ($9.9b) ($7.1b) ($3.1b)
Increase (decrease) in provisions $20.5b ($6.5b) $47.1b $21.9b $49.1b ($58.1b) $31.9b ($126.9b) $45.2b $416.1b
Decrease in other financial liabilities — — ($4.0b) $7.2b $173.4b ($49.6b) $31.7b ($18.6b) ($3.5b) ($81.6b)
Settlement of forward exchange contracts, net — — — — — — — ($46.6b) $5.9b $129.7b
Other, net ($4.9b) ($4.1b) ($14.3b) ($3.9b) ($172.0m) ($385.0m) ($9.2b) ($26.1b) ($16.6b) ($13.0b)
Cash generated from operations $302.1b $407.7b $373.4b $896.5b $1.2t $1.3t $1.2t $918.4b $1.2t $1.2t
Tax refunds and interest on tax refunds received $12.5b $25.0b $6.6b $7.8b $34.1b $7.3b $12.5b $17.9b $20.2b $7.8b
Interest received $2.0b $2.4b $6.3b $11.5b $1.1b $2.9b $5.1b $11.2b $17.7b $17.4b
Acquisition of intangible assets ($50.4b) ($61.3b) ($56.4b) ($90.6b) ($125.3b) ($62.8b) ($493.0b) ($305.3b) ($147.0b) ($234.9b)
Acquisition of option to license — — — — — — $0 $0 ($31.8b) ($3.7b)
Acquisition of investments ($12.1b) ($16.9b) ($17.1b) ($7.6b) ($12.6b) ($8.3b) ($10.2b) ($6.8b) ($97.5b) ($15.9b)
Acquisition of shares in associates — — — — — — $0 $0 ($1.0b) ($623.0m)
Proceeds from sales of shares in associates — — — — — — $0 $0 $57.7b $880.0m
Settlement of forward exchange contracts designated as net investment hedges, net — — — — — $0 $0 ($33.3b) ($13.8b) ($1.5b)
Net increase (decrease) in short-term loans and commercial papers $407.0b ($403.9b) $367.3b ($351.2b) ($149.0b) ($2.0m) $40.0b $277.0b $27.5b ($341.8b)
Proceeds from issuance of bonds and long-term loans $260.2b $393.5b $2.8t $496.2b $1.2t $249.3b $75.0b $100.0b $1.0t $586.1b
Repayments of bonds and long-term loans ($191.8b) ($140.0b) $0 ($701.1b) ($1.7t) ($810.1b) ($356.7b) ($320.9b) ($1.3t) ($200.4b)
Settlement of cross currency interest swaps related to bonds and loans — — — — — $0 $0 $60.1b $46.9b $0
Acquisition of treasury shares ($23.1b) ($18.8b) ($1.2b) ($3.7b) ($2.1b) ($77.5b) ($26.9b) ($2.3b) ($51.9b) ($51.6b)
Repayments of lease liabilities — — ($1.7b) ($30.0b) ($39.3b) ($39.7b) ($43.4b) ($54.6b) ($45.2b) ($42.8b)
Beginning Cash Position — — — — — — $849.7b $533.5b $457.8b $385.1b
Cash Flow From Continuing Financing Activities — — — — — — ($709.1b) ($354.4b) ($751.4b) ($496.8b)
Cash Flow From Continuing Investing Activities — — — — — — ($607.1b) ($463.9b) ($367.1b) ($369.1b)
Change In Inventory — — — — — — ($79.2b) ($115.7b) ($35.0b) ($61.3b)
Change In Other Current Liabilities — — — — — — $31.7b ($18.6b) ($3.5b) ($81.6b)
Change In Other Working Capital — — — — — — $31.9b ($126.9b) $45.2b $416.1b
Change In Payable — — — — — — ($84.8b) ($9.9b) ($7.1b) ($3.1b)
Change In Payables And Accrued Expense — — — — — — ($84.8b) ($9.9b) ($7.1b) ($3.1b)
Change In Receivables — — — — — — $75.1b $15.1b ($59.0b) ($70.2b)
Change In Working Capital — — — — — — ($25.3b) ($256.0b) ($59.4b) $199.9b
Changes In Cash — — — — — — ($339.1b) ($101.9b) ($61.3b) $175.5b
End Cash Position — — — — — — $533.5b $457.8b $385.1b $595.1b
Financing Cash Flow — — — — — — ($709.1b) ($354.4b) ($751.4b) ($496.8b)
Free Cash Flow — — — — — — $343.5b $235.6b $677.6b $626.8b
Gain Loss On Investment Securities — — — — — — — ($46.6b) $5.9b $129.7b
Gain Loss On Sale Of Business — — — — — — ($6.8b) ($7.8b) ($10.2b) ($18.3b)
Gain Loss On Sale Of PPE — — — — — — $10.0m $6.1b $4.5b $3.1b
Interest Received CFI — — — — — — $5.1b $11.2b $17.7b $17.4b
Investing Cash Flow — — — — — — ($607.1b) ($463.9b) ($367.1b) ($369.1b)
Net Business Purchase And Sale — — — — — — $8.0b $20.0b $77.2b $33.6b
Net Intangibles Purchase And Sale — — — — — — ($493.0b) ($305.3b) ($178.8b) ($238.7b)
Net PPE Purchase And Sale — — — — — — ($139.7b) ($166.8b) ($200.7b) ($169.5b)
Operating Gains Losses — — — — — — $1.8b ($54.8b) $4.2b $116.7b
Other Non Cash Items — — — — — — $18.0b $206.8b $147.5b $99.1b
Purchase Of Business — — — — — — $0 $0 ($1.0b) ($623.0m)
Purchase Of Intangibles — — — — — — ($493.0b) ($305.3b) ($178.8b) ($238.7b)
Purchase Of PPE — — $77.7b $127.1b $111.2b $123.3b ($140.7b) ($175.4b) ($200.8b) ($176.0b)
Repurchase Of Capital Stock — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b)
Sale Of Business — — — — — — $8.0b $20.0b $78.2b $34.2b
Sale Of PPE — — — — — — $962.0m $8.6b $78.0m $6.5b
Stock Based Compensation — — — — — — $60.7b $70.9b $72.9b $72.8b
Unrealized Gain Loss On Investment Securities — — — — — — $4.0b $20.8b ($602.0m) $1.0b
Profit or Loss — — $109.0b $44.3b $376.2b $230.2b $317.0b $144.2b $108.1b —
Cash flows from investing activities:
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $2.6b $3.0b $50.7b $12.6b $46.5b $1.8b $962.0m $8.6b $78.0m $6.5b
Capital Expenditure — — — — — — ($633.7b) ($480.7b) ($379.6b) ($414.7b)
Net Investment Purchase And Sale — — — — — — $12.1b ($32.0b) ($81.9b) ($10.4b)
Purchase Of Investment — — — — — — ($10.2b) ($40.1b) ($111.4b) ($17.4b)
Proceeds from sales and redemption of investments $5.3b $40.7b $65.0b $49.4b $74.6b $16.9b $22.3b $8.0b $29.4b $7.0b
Sale Of Investment — — — — — — $22.3b $8.0b $29.4b $7.0b
Gain on divestment of business and subsidiaries ($115.4b) ($134.1b) ($83.0b) ($16.8b) ($230.0b) ($7.8b) ($6.8b) ($7.8b) ($10.2b) ($18.3b)
Proceeds from sales of business, net of cash and cash equivalents divested $64.4b $85.1b $85.1b $461.5b $530.4b $28.2b $8.0b $20.0b $20.6b $33.3b
Net Other Investing Changes — — — — — — ($3.1b) ($4.0b) ($1.1b) ($2.8b)
Cash flows from financing activities:
Issuance Of Debt — — — — — — $115.0b $377.0b $1.1t $586.1b
Long Term Debt Issuance — — — — — — $75.0b $100.0b $1.0t $586.1b
Net Issuance Payments Of Debt — — — — — — ($285.1b) $1.5b ($314.3b) $1.1b
Net Long Term Debt Issuance — — — — — — ($325.1b) ($275.5b) ($341.8b) $342.9b
Net Short Term Debt Issuance — — — — — — $40.0b $277.0b $27.5b ($341.8b)
Short Term Debt Issuance — — — — — — $40.0b $277.0b $27.5b —
Long Term Debt Payments — — — — — — ($400.1b) ($375.5b) ($1.4t) ($243.2b)
Repayment Of Debt — — — — — — ($400.1b) ($375.5b) ($1.4t) ($585.0b)
Short Term Debt Payments — — — — — ($2.0m) — — — ($341.8b)
Net Common Stock Issuance — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b)
Common Stock Payments — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b)
Dividends paid ($141.7b) ($141.9b) $142.9b $282.8b $283.8b $284.2b $278.3b $287.8b $303.2b ($311.9b)
Dividends Paid Classified As Financing Activities — — $143.0b $282.6b $283.4b $283.7b $279.4b $287.2b $302.5b —
Dividends received $3.7b $7.7b $2.7b $1.4b $387.0m $3.4b $3.6b $13.2b $635.0m $1.3b
Cash Dividends Paid — — — — — — ($279.4b) ($287.2b) ($302.5b) ($311.9b)
Common Stock Dividend Paid — — — — — ($283.7b) ($279.4b) — — —
Dividends Received CFI — — — — — — $3.6b $13.2b $635.0m $1.3b
Net Other Financing Charges — — — — — — ($9.2b) $34.0b $30.2b ($13.0b)
Effects of exchange rate changes on cash and cash equivalents ($5.7b) ($4.6b) ($31.3b) ($21.8b) $12.5b $28.8b $22.9b $26.2b ($11.4b) $34.5b
Effect Of Exchange Rate Changes — — — — — — $22.9b $26.2b ($11.4b) $34.5b
Net increase (decrease) in cash and cash equivalents ($104.4b) ($41.7b) $439.0b ($43.3b) $316.1b ($145.3b) ($339.1b) ($101.9b) ($61.3b) $175.5b
Cash and cash equivalents at the beginning of the year $319.5b $294.5b $702.1b $637.6b $966.2b $849.7b $533.5b $457.8b $385.1b $595.1b
Change In Cash Supplemental As Reported — — — — — — ($339.1b) ($101.9b) ($61.3b) $175.5b
Interest Paid Classified As Financing Activities ($7.0b) ($8.4b) $34.9b $11.8b $107.3b $108.2b $108.6b $100.4b $113.0b ($121.4b)
Income taxes paid ($53.2b) ($54.9b) ($51.5b) ($234.6b) ($235.8b) ($147.7b) ($198.4b) ($219.9b) ($170.6b) ($180.4b)

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.